These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 21168857)

  • 1. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance.
    Sleeper LA; Minich LL; McCrindle BM; Li JS; Mason W; Colan SD; Atz AM; Printz BF; Baker A; Vetter VL; Newburger JW;
    J Pediatr; 2011 May; 158(5):831-835.e3. PubMed ID: 21168857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
    Iio K; Morikawa Y; Miyata K; Kaneko T; Misawa M; Yamagishi H; Miura M
    J Pediatr; 2022 Jan; 240():158-163.e4. PubMed ID: 34461064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
    Fabi M; Andreozzi L; Corinaldesi E; Bodnar T; Lami F; Cicero C; Tchana B; Landini C; Sprocati M; Bigucci B; Balsamo C; Sogno Valin P; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
    Eur J Pediatr; 2019 Mar; 178(3):315-322. PubMed ID: 30499051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.
    Sánchez-Manubens J; Antón J; Bou R; Iglesias E; Calzada-Hernandez J; Borlan S; Gimenez-Roca C; Rivera J;
    Rheumatol Int; 2016 Jul; 36(7):905-10. PubMed ID: 27215220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
    Chantasiriwan N; Silvilairat S; Makonkawkeyoon K; Pongprot Y; Sittiwangkul R
    Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Japanese Kawasaki Disease Scoring Systems: Are they Applicable to the Iranian Population?
    Edraki MR; Mohammadi H; Mehdizadegan N; Ghorashi M; Amoozgar H; Borzouee M; Ajami G; Keshavarz K; Dehghani E; Bahrami R
    Arch Iran Med; 2020 Jan; 23(1):31-36. PubMed ID: 31910632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: a multicenter study.
    Kanai T; Takeshita S; Kawamura Y; Kinoshita K; Nakatani K; Iwashima S; Takizawa Y; Hirono K; Mori K; Yoshida Y; Nonoyama S
    Heart Vessels; 2020 Oct; 35(10):1463-1472. PubMed ID: 32449049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
    Miyata K; Kaneko T; Morikawa Y; Sakakibara H; Matsushima T; Misawa M; Takahashi T; Nakazawa M; Tamame T; Tsuchihashi T; Yamashita Y; Obonai T; Chiga M; Hori N; Komiyama O; Yamagishi H; Miura M;
    Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The factors affecting the disease course in Kawasaki disease.
    Arslanoglu Aydin E; Ertugrul I; Bilginer Y; Batu ED; Sonmez HE; Demir S; Arici ZS; Sag E; Alehan D; Ozen S
    Rheumatol Int; 2019 Aug; 39(8):1343-1349. PubMed ID: 31139951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease.
    Takeshita S; Kanai T; Kawamura Y; Yoshida Y; Nonoyama S
    PLoS One; 2017; 12(5):e0176957. PubMed ID: 28542183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verification of Current Risk Scores for Kawasaki Disease in Korean Children.
    Shin J; Lee H; Eun L
    J Korean Med Sci; 2017 Dec; 32(12):1991-1996. PubMed ID: 29115081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verification of risk scores to predict i.v. immunoglobulin resistance in incomplete Kawasaki disease.
    Kanamitsu K; Kakimoto H; Shimada A; Nakata Y; Ochi H; Watanabe H; Iwasaki Y; Tokorodani C; Kanazawa A; Maruyama H; Miyazawa M; Nishiuchi R; Kikkawa K
    Pediatr Int; 2016 Feb; 58(2):146-51. PubMed ID: 26190225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of risk scores for predicting intravenous immunoglobulin resistance in Taiwanese patients with Kawasaki disease.
    Huang CN; Wu FF; Chang YM; Huang HC; Lin MT; Wang JK; Wu MH
    J Formos Med Assoc; 2021 Oct; 120(10):1884-1889. PubMed ID: 33358267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
    Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the Egami Score in Predicting Intravenous Immunoglobulin Resistance in Kawasaki Disease Among Different Ethnicities.
    Loomba RS; Raskin A; Gudausky TM; Kirkpatrick E
    Am J Ther; 2016; 23(6):e1293-e1299. PubMed ID: 25611359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial.
    Fukui S; Seki M; Minami T; Kotani K; Oka K; Yokomizo A; Matsubara D; Sato T; Nozaki Y; Saito M; Kikuchi Y; Miyamoto K; Monden Y; Yamagata T
    Pediatr Rheumatol Online J; 2021 Jul; 19(1):107. PubMed ID: 34217297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of intravenous immunoglobulin in the treatment of Kawasaki disease.
    Lo MS; Newburger JW
    Int J Rheum Dis; 2018 Jan; 21(1):64-69. PubMed ID: 29205910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation of a risk score to predict intravenous immunoglobulin resistance in patients with kawasaki disease.
    Seki M; Kobayashi T; Kobayashi T; Morikawa A; Otani T; Takeuchi K; Ayusawa M; Tsuchiya K; Yasuda K; Suzuki T; Shimoyama S; Ikeda K; Ishii Y; Arakawa H
    Pediatr Infect Dis J; 2011 Feb; 30(2):145-7. PubMed ID: 20802375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of left ventricular function in immunoglobulin-resistant children with Kawasaki disease: a two-dimensional speckle tracking echocardiography study.
    Wang H; Shang J; Tong M; Song Y; Ruan L
    Clin Cardiol; 2019 Aug; 42(8):753-759. PubMed ID: 31173382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive therapies in Kawasaki disease.
    Tremoulet AH
    Int J Rheum Dis; 2018 Jan; 21(1):76-79. PubMed ID: 29076637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.